Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Catalyst Pharmaceutical Partners Inc buy Cantor Fitzgerald

Catalyst Pharmaceutical Partners Inc
Start price
€14.55
22.03.24 / 50%
Target price
€31.46
22.03.25
Performance (%)
-5.36%
Price
€13.77
23.04.24
Summary
This prediction is currently active. With a performance of -5.36%, the BUY prediction for Catalyst Pharmaceutical Partners Inc by Cantor_Fitzgerald is down slightly. This prediction currently runs until 22.03.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Catalyst Pharmaceutical Partners Inc -5.782% -5.782%
iShares Core DAX® 2.594% -1.861%
iShares Nasdaq 100 3.553% -2.064%
iShares Nikkei 225® 0.687% -8.704%
iShares S&P 500 2.209% -1.988%

Comments by Cantor_Fitzgerald for this prediction

In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Prediction Buy
Perf. (%) -5.36%
Target price 31.457
Change
Ends at 22.03.25

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $34.00 price target on the stock.
Ratings data for CPRX provided by MarketBeat

Cantor Fitzgerald 
0
Report Share
22.03.24

Stopped prediction by Cantor_Fitzgerald for Catalyst Pharmaceutical Partners Inc

buy
Catalyst Pharmaceutical Partners Inc

Start price
Target price
Perf. (%)
€16.00
01.03.24
€31.37
01.03.25
-13.94%
23.04.24

Cantor Fitzgerald 
01.03.24 50%